PQA Home PQA Home Phone (703) 690-1987
Contact Us Online
"Optimizing Patients' Health by Improving the Quality of Medication Use"
HOME ABOUT PQA ACADEMIC MEASURES MEMBERSHIP MDTs and SAPs RESOURCES
 
PQA Measure Development



PQA Newsletter



 
Pharmacy Quality Alliance

6213 Old Keene Mill Court
Springfield, VA   22152

Phone: (703) 690-1987
Fax: (703) 842-8150

To contact us, email:
info@pqaalliance.org
or click here.

PQA Stakeholder Advisory Panels (SAP)


PQA member key contacts appoint representatives to Stakeholder Advisory Panels using the online form February 3-22, 2017.

Stakeholder Advisory Panels are larger groups, composed of PQA members, to provide input to Measure Development Teams and Task Forces on measure concepts under development. Key contacts from PQA member organizations can appoint individuals from their organization to participate on these panels, which meet quarterly and in-person at the PQA Annual Meeting.

Each PQA member organization can appoint up to SIX (6) individuals to participate on Stakeholder Advisory Panels (SAPs), with a maximum of two (2) appointees per SAP.


For 2017, PQA will have 3 Stakeholder Advisory Panels. The measure concepts that each will provide input on have been grouped into similar topic areas.

Stakeholder Advisory Panel A - Specialty and Pharmacy  
*Co-chairs assignment planning in progress. Members will be notified upon finalization. 
SAP A Focus
MS TF:  Use of Disease Modifying Therapy in Persons with Relapsing Forms of Multiple Sclerosis;

Magnetic Resonance Imaging (MRI) Prior to Initiating or Switching Disease Modifying Therapy (DMT) in Patients with Relapsing Forms of Multiple Sclerosis; 

MRI to Establish a New Baseline After Initiating or Switching DMT in Patients with Relapsing Forms of Multiple Sclerosis; 

MRI for Follow-Up in Patients with Relapsing Forms of Multiple Sclerosis Being Treated with DMT




Stakeholder Advisory Panel B - Medication Therapy Management  
*Co-chairs assignment planning in progress. Members will be notified upon finalization. 
SAP B Focus
  • MDT 9: MTM: Medication Therapy Problem Resolution
  • MDT 14: Next Generation MTM Measure (new concept for 2017)
  • Adult IZ TF 2: Immunization Status Assessment within MTM; ACIP Compliance Following IZ Status Assessment



Stakeholder Advisory Panel C - Safe and Appropriate Medication Use  
*Co-chairs assignment planning in progress. Members will be notified upon finalization. 
SAP C Focus
  • MDT 12: Inappropriate Duplicate Therapy
  • Adult IZ TF 3: ACIP Schedule Completion in Patients with Diabetes (new concept for 2017)



ACIP = Advisory Committee on Immunization Practices; DMT = Disease Modifying Therapy; IZ = Immunization; MRI = Magnetic Resonance Imaging; MS = Multiple Sclerosis; MTM = Medication Therapy Management; RRMS = Relapsing Remitting Multiple Sclerosis; TF = Task Force






 
© Copyright 2017 Pharmacy Quality Alliance | Site Development & Hosting By ISADEX Corporation | Connections | Terms | Privacy Visit Us On Facebook      Visit Us On Twitter      Visit Us On LinkedIn